Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer

NCT00001496 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00001496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
January 31, 1996
Completion date
November 30, 2001
Enrollment
50
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm, hereditary neoplastic syndrome